Neurocrine Biosciences
NBIX
#1573
Rank
NZ$23.12 B
Marketcap
NZ$230.42
Share price
-0.72%
Change (1 day)
23.10%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company